ATE404560T1 - Indazol- und indolonderivative und deren verwendung als pharmazeutika - Google Patents

Indazol- und indolonderivative und deren verwendung als pharmazeutika

Info

Publication number: ATE404560T1
Authority: AT; Austria
Prior art keywords: pharmaceutics; indazole; indolone derivatives; indolone; derivatives
Prior art date: 2004-05-26

Application number

AT05742759T

Other languages

English (en)

Inventor

Charlotte Moira Norfo Allerton

David Hepworth

Duncan Charles Miller

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-26

Filing date

2005-05-17

Publication date

2008-08-15

2004-05-26 Priority claimed from GB0411810A external-priority patent/GB0411810D0/en

2004-07-09 Priority claimed from GB0415455A external-priority patent/GB0415455D0/en

2005-05-17 Application filed by Pfizer filed Critical Pfizer

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE404560T1 publication Critical patent/ATE404560T1/de

Links

BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
150000005624 indolones Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT05742759T 2004-05-26 2005-05-17 Indazol- und indolonderivative und deren verwendung als pharmazeutika ATE404560T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0411810A GB0411810D0 (en)	2004-05-26	2004-05-26	New indazole and indolone derivatives and their use as pharmaceuticals
GB0415455A GB0415455D0 (en)	2004-07-09	2004-07-09	New indazole and indolone derivatives and their use as pharmaceuticals

Publications (1)

Publication Number	Publication Date
ATE404560T1 true ATE404560T1 (de)	2008-08-15

Family

ID=35219654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05742759T ATE404560T1 (de)	2004-05-26	2005-05-17	Indazol- und indolonderivative und deren verwendung als pharmazeutika

Country Status (25)

Country	Link
EP (1)	EP1753763B1 (de)
JP (2)	JP4093588B2 (de)
AP (1)	AP2006003823A0 (de)
AR (1)	AR049191A1 (de)
AT (1)	ATE404560T1 (de)
AU (1)	AU2005247696A1 (de)
BR (1)	BRPI0511533A (de)
CA (1)	CA2568050A1 (de)
CR (1)	CR8772A (de)
DE (1)	DE602005008954D1 (de)
EA (1)	EA200601985A1 (de)
EC (1)	ECSP067024A (de)
ES (1)	ES2308492T3 (de)
GT (1)	GT200500118A (de)
IL (1)	IL179365A0 (de)
MA (1)	MA28606B1 (de)
MX (1)	MXPA06013759A (de)
NL (1)	NL1029128C2 (de)
NO (1)	NO20065328L (de)
PA (1)	PA8635001A1 (de)
PE (1)	PE20060289A1 (de)
SV (1)	SV2005002128A (de)
TW (1)	TW200607500A (de)
UY (1)	UY28918A1 (de)
WO (1)	WO2005116027A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR078411A1 (es)	2009-05-07	2011-11-09	Lilly Co Eli	Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
CA2860453C (en) *	2011-01-24	2020-04-28	Inceptum Research & Therapeutics, Inc.	Compositions comprising a prostaglandin for treating neuropsychiatric conditions
CA2965741C (en) *	2014-11-03	2022-05-17	Iomet Pharma Ltd	Pharmaceutical compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993023035A2 (en) *	1992-05-18	1993-11-25	Smithkline Beecham Plc	Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
AU6246198A (en) *	1997-02-18	1998-09-08	American Home Products Corporation	4-aminoethoxyindazole derivatives
GB0130219D0 (en) *	2001-12-18	2002-02-06	Pfizer Ltd	Compounds for the treatment of sexual dysfunction
PT1572214E (pt) *	2002-12-10	2010-05-06	Pfizer	Morfolina derivados para utilização como agonistas da dopamina no tratamento da disfunção sexual i.a.

2005
- 2005-05-17 WO PCT/IB2005/001513 patent/WO2005116027A2/en not_active Ceased
- 2005-05-17 AT AT05742759T patent/ATE404560T1/de not_active IP Right Cessation
- 2005-05-17 EP EP05742759A patent/EP1753763B1/de not_active Expired - Lifetime
- 2005-05-17 EA EA200601985A patent/EA200601985A1/ru unknown
- 2005-05-17 DE DE602005008954T patent/DE602005008954D1/de not_active Expired - Fee Related
- 2005-05-17 ES ES05742759T patent/ES2308492T3/es not_active Expired - Lifetime
- 2005-05-17 BR BRPI0511533-7A patent/BRPI0511533A/pt not_active IP Right Cessation
- 2005-05-17 MX MXPA06013759A patent/MXPA06013759A/es unknown
- 2005-05-17 AU AU2005247696A patent/AU2005247696A1/en not_active Abandoned
- 2005-05-17 AP AP2006003823A patent/AP2006003823A0/xx unknown
- 2005-05-17 CA CA002568050A patent/CA2568050A1/en not_active Abandoned
- 2005-05-17 JP JP2007514182A patent/JP4093588B2/ja not_active Expired - Fee Related
- 2005-05-20 GT GT200500118A patent/GT200500118A/es unknown
- 2005-05-23 PE PE2005000570A patent/PE20060289A1/es not_active Application Discontinuation
- 2005-05-24 AR ARP050102145A patent/AR049191A1/es unknown
- 2005-05-24 UY UY28918A patent/UY28918A1/es not_active Application Discontinuation
- 2005-05-25 NL NL1029128A patent/NL1029128C2/nl not_active IP Right Cessation
- 2005-05-25 TW TW094117076A patent/TW200607500A/zh unknown
- 2005-05-26 PA PA20058635001A patent/PA8635001A1/es unknown
- 2005-05-26 SV SV2005002128A patent/SV2005002128A/es not_active Application Discontinuation
2006
- 2006-11-16 IL IL179365A patent/IL179365A0/en unknown
- 2006-11-20 NO NO20065328A patent/NO20065328L/no unknown
- 2006-11-24 CR CR8772A patent/CR8772A/es unknown
- 2006-11-24 EC EC2006007024A patent/ECSP067024A/es unknown
- 2006-11-24 MA MA29487A patent/MA28606B1/fr unknown
2007
- 2007-12-11 JP JP2007320093A patent/JP2008074874A/ja active Pending

Also Published As

Publication number	Publication date
PE20060289A1 (es)	2006-04-22
IL179365A0 (en)	2007-03-08
WO2005116027A3 (en)	2006-04-13
TW200607500A (en)	2006-03-01
BRPI0511533A (pt)	2008-01-02
ES2308492T3 (es)	2008-12-01
NL1029128A1 (nl)	2005-11-30
DE602005008954D1 (de)	2008-09-25
EP1753763B1 (de)	2008-08-13
MXPA06013759A (es)	2007-02-08
EP1753763A2 (de)	2007-02-21
JP2008500329A (ja)	2008-01-10
GT200500118A (es)	2006-01-10
AU2005247696A1 (en)	2005-12-08
JP4093588B2 (ja)	2008-06-04
NL1029128C2 (nl)	2006-06-14
ECSP067024A (es)	2006-12-29
EA200601985A1 (ru)	2007-04-27
CA2568050A1 (en)	2005-12-08
MA28606B1 (fr)	2007-05-02
PA8635001A1 (es)	2006-05-16
CR8772A (es)	2006-12-13
WO2005116027A2 (en)	2005-12-08
UY28918A1 (es)	2005-12-30
JP2008074874A (ja)	2008-04-03
SV2005002128A (es)	2005-12-13
NO20065328L (no)	2006-12-18
AR049191A1 (es)	2006-07-05
AP2006003823A0 (en)	2006-12-31

Legal Events

Date	Code	Title	Description
2009-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE543808T1 (de)	2012-02-15	5,6-ring-annelierte indolderivate und ihre verwendung
ATE378338T1 (de)	2007-11-15	Pyrrolopyridinderivate und deren verwendung als crth2-antagonisten
ATE430754T1 (de)	2009-05-15	Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE602005015699D1 (de)	2009-09-10	Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
DE602005023639D1 (de)	2010-10-28	Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten
DE602005022115D1 (de)	2010-08-12	Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren
DE602006012060D1 (de)	2010-03-18	Bicyclische bisamidderivate und deren anwendung als insektizide
DE602005016162D1 (de)	2009-10-01	Benzimidazolderivate und ihre Verwendung als AII Rezeptor-Antagonist
ATE542816T1 (de)	2012-02-15	Azabicycloä3.1.0ühexanderivate und ihre verwendung als modulatoren des dopamin-d3- rezeptors
ATE426597T1 (de)	2009-04-15	Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
DE602005009811D1 (de)	2008-10-30	Tetrahydrocarbazole und derivate
DE50311397D1 (de)	2009-05-20	Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitoren
ATE478059T1 (de)	2010-09-15	Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten
ATE471938T1 (de)	2010-07-15	Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten
ATE454377T1 (de)	2010-01-15	2-phenyl-6-aminocarbonylpyrimidinderivate und ihre verwendung als antagonisten am p2y12- rezeptor
DE602004022458D1 (de)	2009-09-17	Pyrazolderivate und ihre verwendung als orexin-rezeptor-antagonisten
ATE511507T1 (de)	2011-06-15	Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
ATE396185T1 (de)	2008-06-15	Substituierte 4-alkyl- und 4- alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten
ATE517098T1 (de)	2011-08-15	Acylaminothiazolderivate und deren verwendung als beta-amyloid-inhibitoren
ATE442366T1 (de)	2009-09-15	Oxazolidinonderivate und ihre verwendung als antibiotika
DE602006004713D1 (de)	2009-02-26	Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
DE602005022060D1 (de)	2010-08-12	Diaminoalkohole und deren verwendung als renininhibitoren
DE602006017183D1 (de)	2010-11-11	Benzimidazolderivat und anwendung davon
ATE555097T1 (de)	2012-05-15	4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
ATE468338T1 (de)	2010-06-15	Pyrrolochinolinderivate und ihre verwendung als proteinkinasehemmer